Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 4;15(3):840.
doi: 10.3390/pharmaceutics15030840.

Prevalence, Risk, and Challenges of Extemporaneous Preparation for Pediatric Patients in Developing Nations: A Review

Sri Hartati Yuliani  1 , Dina Christin Ayuning Putri  1 , Dita Maria Virginia  2 , Michael Raharja Gani  3 , Florentinus Dika Octa Riswanto  3
Affiliations
Review

Prevalence, Risk, and Challenges of Extemporaneous Preparation for Pediatric Patients in Developing Nations: A Review

Sri Hartati Yuliani et al. Pharmaceutics. .

Abstract

Extemporaneous preparations are still widely prescribed for pediatric patients with special treatments of certain doses and/or combinations of drugs. Several problems related to extemporaneous preparations have been linked to the incidence of adverse events or a lack of therapeutic effectiveness. Developing nations are facing the challenges of compounding practices. The prevalence of compounded medication in developing nations must be explored to determine the urgency of compounding practices. Furthermore, the risks and challenges are described and explained through investigation and collection of numerous scientific articles from reputable databases, including Web of Science, Scopus, and PubMed. Pediatric patients need compounded medication related to the appropriate dosage form and dosage adjustment. Notably, it is important to observe extemporaneous preparations in order to provide patient-oriented medication.

Keywords: developing nations; extemporaneous preparation; pediatric.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Burch J. Compounding Pharmacists Provide Customized Care. N. Carol. Med. J. 2017;78:191–194. doi: 10.18043/ncm.78.3.191. - DOI - PubMed
    1. Alkhatib H.S., Jalouqa S., Maraqa N., Ratka A., Elayeh E., Al Muhaissen S. Prevalence, Determinants, and Characteristics of Extemporaneous Compounding in Jordanian Pharmacies. BMC Health Serv. Res. 2019;19:816. doi: 10.1186/s12913-019-4684-y. - DOI - PMC - PubMed
    1. Fátima R. Paediatric Medicines: Formulation Considerations. Arch. Pharm. Pharm. Sci. 2017;1:24–27. doi: 10.29328/journal.hps.1001004. - DOI
    1. Moulis F., Durrieu G., Lapeyre-Mestre M. Off-Label and Unlicensed Drug Use in Children Population. Therapie. 2018;73:135–149. doi: 10.1016/j.therap.2018.02.002. - DOI - PubMed
    1. Mohiuddin A. Extemporaneous Compounding: Selective Pharmacists with Separate Skill. Inov. Pharm. 2019;10:3. doi: 10.24926/iip.v10i4.1660. - DOI - PMC - PubMed

LinkOut - more resources